TNX-4800 is a long-acting anti-Borrelia burgdorferi OspA human monoclonal antibody in development as a single-dose Lyme prophylactic Phase 1 ...

New Rhapsido® REMIX-1 & -2 pooled analysis on symptom control as early as week 1 in chronic spontaneous urticaria (CSU) to be ...

Company expects to initiate a randomized, double-blind, placebo-controlled, adaptive Phase 2 field study in the first half of 2027, pending FDA clearance BERKELEY HEIGHTS, N.J., March 31, 2026 (GLOBE ...

PARG is a next-generation DDR target with significant potential in PARP inhibitor-resistant cancers Preclinical data show ...

Good lord. The post Elon Musk’s Orbital Data Centers Are Staggeringly Huge appeared first on Futurism.

At the AD/PD 2026, Roche showcased new five-year data from the Phase II PASADENA trial (NCT03100149) involving prasinezumab.

Prothena partners presented clinical data updates for prasinezumab for Parkinson’s and BMS-986446 for Alzheimer’s disease at AD/PD™ 2026 ...

Objective To evaluate the impact of an Australian Virtual Care service on low-acuity patient presentations to emergency departments (EDs) across a local health district. Design This was a ...

The crucial utilities sector is getting a boost from A.I. data centers, and VPU is capitalizing on it while delivering solid ...

Moonlit Creative Works has officially announced the public release of Metaphysical Sherpa: The Science of Consciousness, an ...

The study met its primary endpoint of radiographic progression free survival, which was significantly prolonged with the ...